KW 3635

Known as: KW-3635 
 

Topic mentions per year

Topic mentions per year

1990-1999
02419901999

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
The effect of inhibitors of the thromboxane A2 pathway on spontaneous contractions of intestinal smooth muscle preparations was… (More)
Is this relevant?
1997
1997
1. A camptothecin derivative, irinotecan (Cpt-11), is a topoisomerase I inhibitor and has a strong activity against a broad range… (More)
Is this relevant?
1997
1997
The purpose of this study was to elucidate the role of thromboxane A2 (TXA2) in cisplatin-induced apoptosis of mouse renal cells… (More)
Is this relevant?
1994
1994
Antithrombotic effects of KW-3635, a newly synthesized thromboxane (TX) A2-receptor antagonist, were studied in guinea pigs. In… (More)
Is this relevant?
1994
1994
We tested the hypothesis that the abolition of the cyclic flow reduction (CFR) in the canine carotid artery is related to… (More)
Is this relevant?
1994
1994
We studied the effect of KW-3635, a selective thromboxane A2 (TXA2)-receptor antagonist, on experimental glomerulonephritis. The… (More)
Is this relevant?
1994
1994
We investigated the effect of KW-3635, a selective thromboxane (TX) A2-receptor antagonist, on the arachidonic acid (AA)-induced… (More)
Is this relevant?
1993
1993
The effect of KW-3635, a novel thromboxane A2 receptor antagonist, on infarct size was examined in anesthetized dogs subjected to… (More)
Is this relevant?
1993
1993
The antithrombotic effects of the thromboxane (TX) A2-receptor antagonist and aspirin were determined using a photochemically… (More)
Is this relevant?
1993
1993
The effects of KW-3635 (sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl) ethylidene]-6,11-dihydrodibenz-[b,e]oxepine-2… (More)
Is this relevant?